References
- Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis. 2000;31:S24-S28. https://doi.org/10.1086/314056
- EMA. Sales of veterinary antimicrobial agents in 19 EU/EEA countries in 2010. Second ESVAC report. London; European medicines agency; 2012.
- van den Bogaard AE, Stobberingh EE. Antibiotic usage in animals: impact on bacterial resistance and public health. Drugs. 1999;58:589-607. https://doi.org/10.2165/00003495-199958040-00002
- Chae SM, Park EJ, Park S. Antibiotic consumption and expenditures for acute upper respiratory tract infections in outpatients. Yakhak Hoeji. 2013;57:199-204. https://doi.org/10.2807/1560-7917.ES.2016.21.26.30266.
- Paltansing S, Kraakman ME, Ras JM, Wessels E, Bernards AT. Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE. J Antimicrob Chemother. 2013;68:40-45. https://doi.org/10.1093/jac/dks365.
- Hooper DC, Jacoby GA. Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance. Cold Spring Harb Perspect Med. 2016;6:a025320. https://doi.org/10.1101/cshperspect.a025320.
- Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007;60: 394-397. https://doi.org/10.1093/jac/dkm204
- Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 2006;50(11):3953-3955. https://doi.org/10.1128/AAC.00915-06
- Majlesi A, Kakhki RK, Mozaffari Nejad AS, Mashouf RY, Roointan A, Abazari M, et al. Detection of plasmid-mediated quinolone resistance in clinical isolates of Enterobacteriaceae strains in Hamadan, West of Iran. Saudi J Biol Sci. 2018;25:426-430. https://doi.org/10.1016/j.sjbs.2016.11.019.
-
Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, et al. Community-associated extended-spectrum
$bla_{IMP-10}$ -lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56:641-648. https://doi.org/10.1093/cid/cis942. - CLSI. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S20. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute; 2010. p52-53.
- Aoike N, Saga T, Sakata R, Yoshizumi A, Kimura S, Iwata M, et al. Molecular characterization of extraintestinal Escherichia coli isolates in Japan: relationship between sequence types and mutation patterns of quinolone resistance-determining regions analyzed by pyrosequencing. J Clin Microbiol. 2013;51:1692-1698. https://doi.org/10.1128/JCM.03049-12.
- Xia LN, Li L, Wu CM, Liu YQ, Tao XQ, Dai L, et al. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China. Foodborne Pathog Dis. 2010;7:207-215. https://doi.org/10.1089/fpd.2009.0378.
- Kim HB, Wang M, Park CH, Kim EC, Jacoby GA, Hooper DC. oqxAB encoding a multidrug efflux pump in human clinical isolates of 13 Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53:3582-3584. https://doi.org/10.1128/AAC.01574-08.
- Zhao L, Zhang J, Zheng B, Wei Z, Shen P, Li S, et al. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals. J Clin Microbiol. 2015;53:766-770. https://doi.org/10.1128/JCM.02594-14.
- Hu YS, Shin S, Park YH, Park KT. Prevalence and mechanism of fluoroquinolone resistance in Escherichia coli isolated from swine feces in Korea. J Food Prot. 2017;80:1145-1151. https://doi.org/10.4315/0362-028X.JFP-16-502.
- Paltansing S, Kraakman ME, Ras JM, Wessels E, Bernards AT. Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE. J Antimicrob Chemother. 2013;68:40-45. https://doi.org/10.1093/jac/dks365.
- Yeh JC, Lo DY, Chang SK, Chou CC, Kuo HC. Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolated from diseased animals in Taiwan. J Vet Med Sci. 2017;79:730-735. https://doi.org/10.1292/jvms.16-0463.
- Park JM, Choi SS. Molecular characterization of quinolone antibiotic resistance in Escherichia coli isolated from retail meat in Seoul. Yakhak Hoeji. 2016;60:1-7. https://doi.org/10.1186/s13620-017-0095-8.
- Sung JY. The prevalence of plasmid-mediated quinolone resistance genes among CTX-M-14 producing Escherichia coli strains isolated from a university hospital in the Chungcheong province. Korean J Clin Lab Sci. 2016;48:210-216. https://doi.org/10.15324/kjcls.2016.48.3.210.
- Yang HY, Nam YS, Lee HJ. Prevalence of plasmid-mediated quinolone resistance genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in Korea. Can J Infect Dis Med Microbiol. 2014;25:163-169. https://doi.org/10.1155/2014/329541
Cited by
- Comparison of Fluoroquinolone Resistance Determinants in Uropathogenic Escherichia coli between 2 Time Periods of 1989 and 2010-2014 at Gangwon Province in Korea vol.26, pp.2, 2020, https://doi.org/10.15616/bsl.2020.26.2.120